These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9483232)

  • 1. Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New Zealand.
    Lloyd JV; Street AM; Berry E; McPherson J; Ekert H; Lammi A; McWhirter WR; Duncan EM; Maxwell EL; Rowell J; Baker RI; Leahy MF; Jupe D
    Aust N Z J Med; 1997 Dec; 27(6):658-64. PubMed ID: 9483232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
    Mannucci PM; Franchini M
    Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. A French Multicentric Study.
    Fiks-Sigaud M; Bendelac L; Parquet A; Verroust F; Torchet MF; Berthier AM; Fressinaud E; Guerois C; Aillaud MF; Boneu B
    Vox Sang; 1993; 64(4):210-4. PubMed ID: 8517049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A.
    Bowyer A; Shepherd F; Platton S; Guy S; Kitchen S; Maclean R
    Haemophilia; 2020 Nov; 26(6):1181-1186. PubMed ID: 32997894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with highly purified porcine factor VIII in a patient with haemophilia A and a factor VIII inhibitor.
    Colvin BT; Ainsworth M; Buckley C
    Clin Lab Haematol; 1983; 5(1):55-9. PubMed ID: 6406130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I manage patients with inherited haemophilia A and B and factor inhibitors.
    Ljung RCR
    Br J Haematol; 2018 Feb; 180(4):501-510. PubMed ID: 29270992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine factor VIII provides clinical benefit to patients with high levels of inhibitors to human and porcine factor VIII.
    Gribble J; Garvey MB
    Haemophilia; 2000 Sep; 6(5):482-5. PubMed ID: 11012689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in inhibitor reactivity in acquired haemophilia A with different concentrates.
    Sukhu K; Keeling DM; Giangrande PL
    Clin Lab Haematol; 2000 Oct; 22(5):287-90. PubMed ID: 11122270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with haemophilia and inhibitory antibodies.
    Giangrande PL
    Indian J Pediatr; 2003 Aug; 70(8):655-9. PubMed ID: 14510087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII.
    Koshihara K; Qian J; Lollar P; Hoyer LW
    Blood; 1995 Sep; 86(6):2183-90. PubMed ID: 7662967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of polyelectrolyte-fractionated porcine factor VIII in the treatment of a spontaneously acquired inhibitor to factor VIII.
    Hultin MB; Hennessey J
    Thromb Res; 1989 Jul; 55(1):51-6. PubMed ID: 2506662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party.
    Hay CR; Colvin BT; Ludlam CA; Hill FG; Preston FE
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):134-8. PubMed ID: 8735802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors in young boys with haemophilia.
    Lusher JM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary report of the First International Conference on inhibitors in haemophilia A.
    Lacroix-Desmazes S; Scott DW; Goudemand J; Van Den Berg M; Makris M; Van Velzen AS; Santagostino E; Lillicrap D; Rosendaal FR; Hilger A; Sauna ZE; Oldenburg J; Mantovani L; Mancuso ME; Kessler C; Hay CRM; Knoebl P; Di Minno G; Hoots K; Bok A; Brooker M; Buoso E; Mannucci PM; Peyvandi F
    Blood Transfus; 2017 Oct; 15(6):568-576. PubMed ID: 27893354
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VIII inhibitors in mild and moderate-severity haemophilia A.
    Hay CR
    Haemophilia; 1998 Jul; 4(4):558-63. PubMed ID: 9873794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired haemophilia due to autoantibodies against factor VIII].
    von Depka Prondzinski M
    Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.